This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Galis, Z. S. Articles by Moore, S. Search for Related Content PubMed PubMed Citation Articles by Galis, Z. S. Articles by Moore, S.

American Journal of Pathology, Vol 142, 1432-1438, Copyright © 1993 by American Society for Investigative Pathology

REGULAR ARTICLES

Co-localization of aortic apolipoprotein B and chondroitin sulfate in an injury model of atherosclerosis

ZS Galis, MZ Alavi and S Moore
Department of Pathology, McGill University, Montreal, Quebec, Canada.

In vitro, chondroitin sulfate (CS) proteoglycans (PGs) bind with high- affinity lipoproteins (LPs) containing apolipoprotein B (apo B), and cultured monocytes incubated with LP-PG complexes transform into foam cells (FCs). Consequently, arterial PGs are thought to contribute to the accumulation of LPs in atherosclerotic lesions, but their in vivo interaction has yet to be demonstrated. Balloon catheterization of rabbit aorta modifies the normal aortic distribution of endogenous LPs containing apo B, and determines their accumulation in normocholesterolemic conditions. The distribution of aortic CS-PGs parallels that of apoB within the neointima of injured aortas and might contribute to a favorable environment for LP sequestration within the lesions. To visualize the in situ relationship between apo B and CS-PG, we performed experiments for double detection by immunofluorescence and by post-embedding electron microscope immunogold. The results indicated that the colocalization of endogenous LPs containing apo B and of the large intimal CS-PGs in advanced lesions developed under the regenerated endothelium. At the ultrastructural level, frequent associations were visualized in the extracellular space and in relation to FCs. The close spatial relation between CS-PG and apo B inside the aortic lesions seems to support the hypothesis of their in situ interaction and of a simultaneous cellular uptake, and may be related to the development of both extracellular lipid deposits and the formation of FCs in atherogenesis.

This article has been cited by other articles:

				I. Tabas, K. J. Williams, and J. Boren Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications Circulation, October 16, 2007; 116(16): 1832 - 1844. [Abstract] [Full Text] [PDF]

				M. Y. Chang, C. Tsoi, T. N. Wight, and A. Chait Lysophosphatidylcholine Regulates Synthesis of Biglycan and the Proteoglycan Form of Macrophage Colony Stimulating Factor Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 809 - 815. [Abstract] [Full Text] [PDF]

				M. O. Pentikainen, K. Oorni, and P. T. Kovanen Myeloperoxidase and Hypochlorite, but Not Copper Ions, Oxidize Heparin-Bound LDL Particles and Release Them From Heparin Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1902 - 1908. [Abstract] [Full Text] [PDF]

				M. Y. Chang, S. Potter-Perigo, T. N. Wight, and A. Chait Oxidized LDL bind to nonproteoglycan components of smooth muscle extracellular matrices J. Lipid Res., May 1, 2001; 42(5): 824 - 833. [Abstract] [Full Text]

				M. Y. Chang, S. Potter-Perigo, C. Tsoi, A. Chait, and T. N. Wight Oxidized Low Density Lipoproteins Regulate Synthesis of Monkey Aortic Smooth Muscle Cell Proteoglycans That Have Enhanced Native Low Density Lipoprotein Binding Properties J. Biol. Chem., February 18, 2000; 275(7): 4766 - 4773. [Abstract] [Full Text] [PDF]

				P. Sartipy, G. Bondjers, and E. Hurt-Camejo Phospholipase A2 Type II Binds to Extracellular Matrix Biglycan : Modulation of Its Activity on LDL by Colocalization in Glycosaminoglycan Matrixes Arterioscler. Thromb. Vasc. Biol., December 1, 1998; 18(12): 1934 - 1941. [Abstract] [Full Text] [PDF]

				K. D. O'Brien, K. L. Olin, C. E. Alpers, W. Chiu, M. Ferguson, K. Hudkins, T. N. Wight, and A. Chait Comparison of Apolipoprotein and Proteoglycan Deposits in Human Coronary Atherosclerotic Plaques : Colocalization of Biglycan With Apolipoproteins Circulation, August 11, 1998; 98(6): 519 - 527. [Abstract] [Full Text] [PDF]

				M. Romano, E. Romano, S. Bjorkerud, and E. Hurt-Camejo Ultrastructural Localization of Secretory Type II Phospholipase A2 in Atherosclerotic and Nonatherosclerotic Regions of Human Arteries Arterioscler. Thromb. Vasc. Biol., April 1, 1998; 18(4): 519 - 525. [Abstract] [Full Text] [PDF]

				E. Hurt-Camejo, U. Olsson, O. Wiklund, G. Bondjers, and G. Camejo Cellular Consequences of the Association of ApoB Lipoproteins With Proteoglycans: Potential Contribution to Atherogenesis Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1011 - 1017. [Abstract] [Full Text]

				P. G. Steg, M. Ziol, O. Tahlil, C. Robert, P. Masson, D. Pruneau, P. Bruneval, and P. Belichard Reduction of Intimal Hyperplasia by Naroparcil, a 4-Methylumbelliferyl ß-D-Xyloside Analogue, After Arterial Injury in the Hypercholesterolemic Rabbit Circ. Res., November 1, 1995; 77(5): 919 - 926. [Abstract] [Full Text]